Skip to main content

Table 1 Characteristics of subjects

From: Low bone turnover in premenopausal women with type 2 diabetes mellitus as an early process of diabetes-associated bone alterations: a cross-sectional study

  T2DM Non-DM Controls
Number 41 40
Age (years) 45 (41–49) 39 (37–45)
Duration of DM (years) 9 (5–12) NA
BMI (kg/m2) 26 (23–31) 25 (23–29)
HbA1C (%) 10 (7.7–11.6) 5.5 (5.2–5.8)
Creatinine (mg/dl) 0.6 (0.5–0.8) 0.7 (0.6–0.7)
eGFR (mL/min/1,73 m2) 106 (87–115) 110 (106–116)
SGPT (U/l) 19 (11–25) 16 (11–21)
Triglycerides (mg/dl) 158 (96–198) ND
LDL (mg/dl) 141 (117–163) ND
HDL (mg/dl) 49 (38–54) ND
Total cholesterol (mg/dl) 197 (179–230) ND
Antidiabetics
- Metformin (%) 7 (17) NA
- Metformin + Sulfonylurea (%) 11 (27) NA
- Insulin (%) 14 (34) NA
- Combined therapy (%) 8 (20) NA
- No treatment (%) 1 (2) NA
  1. Data depicted are median with interquartile range (IQR) unless otherwise indicated. Statistical differences are analyzed by using T-test or Mann-Whitney U test. NA, not applicable; ND, not determined